HealthEquity, Inc. Revises Earnings Guidance for the Fiscal Year Ended January 31, 2024 and Reaffirms Earnings Guidance for the Fiscal Year Ending January 31, 2025
February 21, 2024 at 04:06 pm EST
Share
HealthEquity, Inc. revised earnings guidance for the fiscal year ended January 31, 2024 and fiscal year ending January 31, 2025. For the fiscal year ended January 31, 2024, the company expected revenue of $995 million to $1 billion. Net income in the range of $49 million to $52 million. Net income per diluted share in the range of $0.56 to $0.60.
For the fiscal year ending January 31, 2025, management affirms revenue of approximately $1.140 billion to $1.160 billion.
HealthEquity, Inc. is engaged in providing technology-enabled services that help consumers make healthcare savings and spending decisions. The Company uses its technology to manage consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It offers a mutual fund investment platform and access to an online-only automated investment advisory service to all its members. It offers multiple cloud-based platforms, accessed by its members online via a desktop or mobile device, through which individuals can make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings and make investment choices.
HealthEquity, Inc. Revises Earnings Guidance for the Fiscal Year Ended January 31, 2024 and Reaffirms Earnings Guidance for the Fiscal Year Ending January 31, 2025
HEALTHEQUITY, INC. 
